본문으로 건너뛰기
← 뒤로

Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer.

2/5 보강
Brain research bulletin 2026 Vol.237() p. 111817 OA Cancer-related cognitive impairment
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-01

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
환자: non-small cell lung cancer (NSCLC) using a longitudinal, within-subject voxel-based F-FDG PET approach
I · Intervention 중재 / 시술
both pre- and post-chemotherapy FDG PET imaging were retrospectively enrolled
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] This within-subject FDG PET study provides longitudinal evidence that chemotherapy independently contributes to brain metabolic alterations in NSCLC patients, predominantly involving the frontal, temporal, and limbic regions. These findings highlight vulnerable neural substrates and underscore the clinical value of functional neuroimaging in cancer survivorship research.
OpenAlex 토픽 · Cancer-related cognitive impairment studies Brain Metastases and Treatment Lung Cancer Research Studies

Cheng HW, Hsiao IT, Huang TW, Lee Y, Yang QF, Chen IF

📖 무료 전문 🔓 OA PDF oa
📝 환자 설명용 한 줄

[BACKGROUND] Chemotherapy-induced cognitive impairment (CICI) is a frequently reported complication in lung cancer patients, yet the underlying cerebral metabolic changes remain poorly characterized.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Hao-Wen Cheng, Ing-Tsung Hsiao, et al. (2026). Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer.. Brain research bulletin, 237, 111817. https://doi.org/10.1016/j.brainresbull.2026.111817
MLA Hao-Wen Cheng, et al.. "Longitudinal voxel-based FDG PET assessment of chemotherapy effects on brain metabolism in lung cancer.." Brain research bulletin, vol. 237, 2026, pp. 111817.
PMID 41819474 ↗

Abstract

[BACKGROUND] Chemotherapy-induced cognitive impairment (CICI) is a frequently reported complication in lung cancer patients, yet the underlying cerebral metabolic changes remain poorly characterized. This study aimed to evaluate chemotherapy-related alterations in brain glucose metabolism in patients with non-small cell lung cancer (NSCLC) using a longitudinal, within-subject voxel-based F-FDG PET approach.

[METHODS] Forty NSCLC patients who underwent both pre- and post-chemotherapy FDG PET imaging were retrospectively enrolled. Voxel-wise comparisons were performed using SPM12 to identify regional metabolic changes. Patients were stratified based on chemotherapy intensity (standard: ≥4 cycles; short-course: 1-3 cycles) and recovery interval (short: <6 months; long: ≥6 months), with subgroup and interaction analyses conducted accordingly.

[RESULTS] Compared with baseline, post-treatment scans revealed regional metabolic reductions, predominantly in the right thalamus, left frontal lobe, and bilateral temporal regions. Patients receiving standard chemotherapy exhibited more extensive metabolic reductions than those receiving short-course treatment, particularly in the bilateral temporal and cingulate regions. Furthermore, patients scanned within six months post-chemotherapy showed more pronounced reductions than those with longer recovery intervals, suggesting a potential trend of metabolic recovery over time. In contrast, patients with limited initial metabolic changes (i.e., short-course group) exhibited minimal changes across intervals.

[CONCLUSION] This within-subject FDG PET study provides longitudinal evidence that chemotherapy independently contributes to brain metabolic alterations in NSCLC patients, predominantly involving the frontal, temporal, and limbic regions. These findings highlight vulnerable neural substrates and underscore the clinical value of functional neuroimaging in cancer survivorship research.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🔓 OA PDF 열기